2/24
04:39 pm
lab
Standard BioTools: Q4 Earnings Snapshot [Yahoo! Finance]
Low
Report
Standard BioTools: Q4 Earnings Snapshot [Yahoo! Finance]
2/24
04:10 pm
lab
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results
2/10
07:00 am
lab
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Low
Report
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
1/30
09:09 am
lab
Standard BioTools Completes Sale of SomaLogic to Illumina
Low
Report
Standard BioTools Completes Sale of SomaLogic to Illumina
1/24
09:07 am
lab
Standard BioTools (NASDAQ:LAB) shareholders have endured a 76% loss from investing in the stock five years ago [Yahoo! Finance]
Low
Report
Standard BioTools (NASDAQ:LAB) shareholders have endured a 76% loss from investing in the stock five years ago [Yahoo! Finance]
1/24
05:10 am
lab
Standard BioTools (NASDAQ:LAB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Standard BioTools (NASDAQ:LAB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/11
04:41 pm
lab
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team [Yahoo! Finance]
Medium
Report
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team [Yahoo! Finance]
1/8
07:00 am
lab
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
High
Report
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
12/28
09:03 am
lab
Standard BioTools: Outlook Still Murky [Seeking Alpha]
Medium
Report
Standard BioTools: Outlook Still Murky [Seeking Alpha]
12/28
08:37 am
lab
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses [Yahoo! Finance]
Medium
Report
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses [Yahoo! Finance]
12/13
07:50 am
lab
Standard BioTools (NASDAQ:LAB) was upgraded by analysts at Zacks Research to a "hold" rating.
Medium
Report
Standard BioTools (NASDAQ:LAB) was upgraded by analysts at Zacks Research to a "hold" rating.